The present invention aims to provide a novel cyclin-dependent kinase 8 and/or 19 inhibitor useful as an anti-cancer agent. The present invention relates to a cyclin-dependent kinase 8 and/or 19 inhibitor containing a compound represented by the formula (I):
[wherein each symbol is as defined in the DESCRIPTION] or a pharmaceutically acceptable salt thereof as an active ingredient, and use thereof as an agent for preventing and/or treating cancer.
本发明旨在提供一种可用作抗癌剂的新型细胞周期蛋白依赖性激酶 8 和/或 19
抑制剂。本发明涉及一种含有由式(I)代表的化合物的细胞周期蛋白依赖性激酶 8 和/或 19
抑制剂:
[其中各符号如说明书中所定义]的化合物或其药学上可接受的盐作为活性成分,并将其用作预防和/或治疗癌症的制剂。